JPMORGAN CHASE & CO - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 94 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,631,514
-3.6%
762,885
-6.5%
0.00%0.0%
Q2 2023$16,219,762
+15.3%
816,294
-0.6%
0.00%0.0%
Q1 2023$14,068,000
+84739.0%
821,275
-3.1%
0.00%0.0%
Q4 2022$16,582
-99.9%
847,321
-16.8%
0.00%0.0%
Q3 2022$16,257,000
+38.7%
1,018,557
+19.6%
0.00%0.0%
Q2 2022$11,718,000
-11.8%
851,594
+1.6%
0.00%0.0%
Q1 2022$13,289,000
-10.9%
837,915
+22.6%
0.00%0.0%
Q4 2021$14,914,000
-39.3%
683,176
-16.9%
0.00%
-33.3%
Q3 2021$24,573,000
-29.9%
822,135
+3.9%
0.00%
-25.0%
Q2 2021$35,032,000
+9.8%
790,971
+10.0%
0.00%0.0%
Q1 2021$31,904,000
+21.8%
719,041
+50.5%
0.00%0.0%
Q4 2020$26,192,000
+418.1%
477,617
+118.1%
0.00%
+300.0%
Q3 2020$5,055,000
+39.8%
218,970
+26.7%
0.00%0.0%
Q2 2020$3,617,000
+57.1%
172,817
+4.7%
0.00%0.0%
Q1 2020$2,302,000
+88.8%
165,015
+208.2%
0.00%
Q4 2019$1,219,000
+969.3%
53,540
+449.2%
0.00%
Q3 2019$114,000
-10.9%
9,749
+19.4%
0.00%
Q2 2019$128,000
+26.7%
8,168
+41.7%
0.00%
Q1 2019$101,000
-70.4%
5,764
-75.0%
0.00%
Q4 2018$341,000
+186.6%
23,020
+376.2%
0.00%
Q3 2018$119,000
-25.6%
4,834
-40.8%
0.00%
Q2 2018$160,0008,1710.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders